Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Delays in diagnosis and treatment of breast cancer: A multinational analysis

  • Jacek Jassem*
  • , Vahit Ozmen
  • , Florin Bacanu
  • , Monika Drobniene
  • , Janis Eglitis
  • , Kuntegowdanahalli C. Lakshmaiah
  • , Zsuzsanna Kahan
  • , Jozef Mardiak
  • , Tadeusz Pieńkowski
  • , Tatiana Semiglazova
  • , Ljiljana Stamatovic
  • , Constanta Timcheva
  • , Suzana Vasovic
  • , Damir Vrbanec
  • , Piotr Zaborek
  • *Šī darba korespondējošais autors
  • Medical University of Gdańsk
  • Istanbul University
  • Sf. Maria Hospital
  • Vilnius University
  • Riga East University Hospital
  • Kidwai Memorial Institute of Oncology
  • University of Szeged
  • Comenius University
  • Medical Centre for Postgraduate Education, Warsaw
  • Russian Ministry of Health
  • Institute for Oncology and Radiology of Serbia
  • Specialized Hospital for Active Treatment in Oncology
  • University of Zagreb
  • SGH Warsaw School Of Economics

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

128 Atsauces (Scopus)

Kopsavilkums

Background: Reducing treatment delay improves outcomes in breast cancer. The aim of this study was to determine factors influencing patient- and system-related delays in commencing breast cancer treatment in different countries. Methods: A total of 6588 female breast cancer patients from 12 countries were surveyed. Total delay time was determined as the sum of the patient-related delay time (time between onset of the first symptoms and the first medical visit) and system-related delay time (time between the first medical visit and the start of therapy). Results: The average patient-related delay time and total delay time were 4.7 (range: 3.4-6.2) weeks and 14.4 (range: 11.5-29.4) weeks, respectively. Longer patient-related delay times were associated with distrust and disregard, and shorter patient-related delay times were associated with fear of breast cancer, practicing self-examination, higher education level, being employed, having support from friends and family and living in big cities. The average system-related delay time was 11.1 (range: 8.3-24.7) weeks. Cancer diagnosis made by an oncologist versus another physician, higher education level, older age, family history of female cancers and having a breast lump as the first cancer sign were associated with shorter system-related delay times. Longer patient-related delay times and higher levels of distrust and disregard were predictors of longer system-related delay times. Conclusions: The delay in diagnosis and treatment of breast cancer remains a serious problem. Several psychological and behavioural patient attributes strongly determine both patient-related delay time and system-related delay time, but their strength is different in particular countries.

OriģinālvalodaAngļu
Lapas (no-līdz)761-767
Lapu skaits7
ŽurnālsEuropean Journal of Public Health
Sējums24
Izdevuma numurs5
DOIs
Publikācijas statussPublicēts - 1 okt. 2014
Ārēji publicētsJā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Delays in diagnosis and treatment of breast cancer: A multinational analysis”. Kopā tie veido unikālu nospiedumu.

Citēt šo